Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Onyx Pharmaceuticals, Inc. (MM) (ONXX)

Onyx Pharmaceuticals, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ONXX
DateTimeSourceHeadlineSymbolCompany
22/11/200413:00PR Newswire (US)Onyx Pharmaceuticals to Present at Lazard Life Sciences ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
04/11/200421:00PR Newswire (US)Onyx Pharmaceuticals Reports Third Quarter and Nine Month 2004 Financial ResultsNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
02/11/200412:00PR Newswire (US)Bayer and Onyx Announce Results of Phase I Studies Evaluating BAY 43-9006 in Combination with Conventional Chemotherapy DrugsNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
01/11/200421:00PR Newswire (US)Onyx Pharmaceuticals Announces Third Quarter 2004 Financial Results Webcast and TeleconferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/10/200413:00PR Newswire (US)FDA Grants Orphan Drug Designation to BAY 43-9006 for the Treatment of Renal Cell CarcinomaNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
25/10/200407:15PR Newswire (US)Onyx Pharmaceuticals Announces a Webcast and Teleconference to Provide an Update on BAY 43-9006NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
25/10/200407:00PR Newswire (US)Bayer and Onyx Announce Positive Phase II Data in Patients With Advanced Kidney CancerNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
23/10/200420:54PR Newswire (US)Onyx Pharmaceuticals Announces a Webcast and Teleconference to Provide an Update on BAY 43-9006NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
29/09/200412:00PR Newswire (US)Bayer and Onyx Announce Phase II Results of Treatment With BAY 43-9006 in Patients with Advanced Primary Liver CancerNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
21/09/200422:00PR Newswire (US)Onyx Pharmaceuticals to Present at UBS Global Life Sciences ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
20/09/200422:00PR Newswire (US)Onyx Pharmaceuticals Achieves Milestone in Cancer Program With PfizerNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
02/09/200422:00PR Newswire (US)Onyx Pharmaceuticals to Present at NewsMakers in the Biotech Industry ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
09/08/200422:00PR Newswire (US)Onyx Pharmaceuticals Reports Second Quarter and Six Month 2004 Financial ResultsNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
04/08/200416:12PR Newswire (US)EMEA Grants Orphan Drug Designation to BAY 43-9006 for the Treatment of Renal Cell CarcinomaNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
02/08/200422:15PR Newswire (US)Onyx Pharmaceuticals Announces Second Quarter 2004 Financial Results Webcast and TeleconferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
09/06/200422:00PR Newswire (US)Onyx Pharmaceuticals to Webcast June 15 Analyst BriefingNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
08/06/200415:04PR Newswire (US)MORNING UPDATE: Man Securities Issues Alerts for GLW, MLNM, EDS, ONXX, and MGGNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
07/06/200422:00PR Newswire (US)Onyx Pharmaceuticals to Present at Upcoming Healthcare ConferencesNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
06/06/200420:00PR Newswire (US)Encouraging Data on BAY 43-9006 in Combination With Standard Chemotherapeutics as Melanoma Treatment Presented at American SocieNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
05/06/200414:45PR Newswire (US)Encouraging Interim Results on BAY 43-9006 in Advanced Kidney Cancer Presented at American Society of Clinical Oncology (ASCO) MNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
03/06/200415:00PR Newswire (US)Onyx Appoints Edward Kenney Executive Vice President and Chief Business OfficerNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
21/05/200415:28PR Newswire (US)MORNING UPDATE: Man Securities Issues Alerts for MU, NAV, NXTP, ONXX, and AESNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
13/05/200422:00PR Newswire (US)Onyx Pharmaceuticals to Present at Banc of America Securities Health Care ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
05/05/200422:00PR Newswire (US)Onyx Pharmaceuticals Reports First Quarter 2004 Financial ResultsNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
19/04/200422:00PR Newswire (US)ONYX Pharmaceuticals to Present at Upcoming ConferencesNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
05/04/200419:25PR Newswire (US)BAY 43-9006 Receives Fast Track Designation From the FDA for Metastatic Kidney Cancer ReviewNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/02/200421:00PR Newswire (US)Onyx Pharmaceuticals to Present at Upcoming Healthcare ConferencesNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
25/02/200418:29PR Newswire (US)Biotech's Helix Award Honors Top Performers Onyx Pharmaceuticals and ActelionNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
18/02/200421:00PR Newswire (US)Onyx Pharmaceuticals to Present at BIO CEO & Investor Conference 2004NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
12/02/200421:01PR Newswire (US)Onyx Pharmaceuticals Reports Fourth Quarter and Year-End 2003 Financial ResultsNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ONXX

Your Recent History

Delayed Upgrade Clock